201 related articles for article (PubMed ID: 25034939)
1. Identification of collaborative driver pathways in breast cancer.
Liu Y; Hu Z
BMC Genomics; 2014 Jul; 15(1):605. PubMed ID: 25034939
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers.
Liu Y; Tian F; Hu Z; DeLisi C
Sci Rep; 2015 May; 5():10204. PubMed ID: 25961669
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive identification of mutational cancer driver genes across 12 tumor types.
Tamborero D; Gonzalez-Perez A; Perez-Llamas C; Deu-Pons J; Kandoth C; Reimand J; Lawrence MS; Getz G; Bader GD; Ding L; Lopez-Bigas N
Sci Rep; 2013 Oct; 3():2650. PubMed ID: 24084849
[TBL] [Abstract][Full Text] [Related]
5. The landscape of cancer genes and mutational processes in breast cancer.
Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
[TBL] [Abstract][Full Text] [Related]
6. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
7. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
8. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
9. Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Santarpia L; Qi Y; Stemke-Hale K; Wang B; Young EJ; Booser DJ; Holmes FA; O'Shaughnessy J; Hellerstedt B; Pippen J; Vidaurre T; Gomez H; Valero V; Hortobagyi GN; Symmans WF; Bottai G; Di Leo A; Gonzalez-Angulo AM; Pusztai L
Breast Cancer Res Treat; 2012 Jul; 134(1):333-43. PubMed ID: 22538770
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
11. Identification of rare cancer driver mutations by network reconstruction.
Torkamani A; Schork NJ
Genome Res; 2009 Sep; 19(9):1570-8. PubMed ID: 19574499
[TBL] [Abstract][Full Text] [Related]
12. Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction.
Pham VV; Zhang J; Liu L; Truong B; Xu T; Nguyen TT; Li J; Le TD
BMC Bioinformatics; 2019 Mar; 20(1):143. PubMed ID: 30876399
[TBL] [Abstract][Full Text] [Related]
13. Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.
Joshi H; Bhanot G; Børresen-Dale AL; Kristensen V
Br J Cancer; 2012 Nov; 107(10):1722-8. PubMed ID: 23079576
[TBL] [Abstract][Full Text] [Related]
14. A Gene Regulatory Program in Human Breast Cancer.
Li R; Campos J; Iida J
Genetics; 2015 Dec; 201(4):1341-8. PubMed ID: 26510790
[TBL] [Abstract][Full Text] [Related]
15. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
16. Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer.
Liu Y; Hu Z; DeLisi C
Mol Cancer Ther; 2016 Jan; 15(1):184-9. PubMed ID: 26625895
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
[TBL] [Abstract][Full Text] [Related]
18. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
Gene; 2022 May; 821():146328. PubMed ID: 35181505
[TBL] [Abstract][Full Text] [Related]
19. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the role of low-frequency mutated genes in breast cancer.
Lusito E; Felice B; D'Ario G; Ogier A; Montani F; Di Fiore PP; Bianchi F
Bioinformatics; 2019 Jan; 35(1):36-46. PubMed ID: 29961866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]